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Innate lymphoid cells (ILCs) are the most abundant immune cells in the uterine mucosa
both before and during pregnancy. Circumstantial evidence suggests they play important
roles in regulating placental development but exactly how they contribute to the
successful outcome of pregnancy is still unclear. Uterine ILCs (uILCs) include subsets
of tissue-resident natural killer (NK) cells and ILCs, and until recently the phenotype and
functions of uILCs were poorly defined. Determining the specific roles of each subset is
intrinsically challenging because of the rapidly changing nature of the tissue both during
the menstrual cycle and pregnancy. Single-cell RNA sequencing (scRNAseq) and high
dimensional flow and mass cytometry approaches have recently been used to analyse
uILC populations in the uterus in both humans and mice. This detailed characterisation
has significantly changed our understanding of the heterogeneity within the uILC
compartment. It will also enable key clinical questions to be addressed including
whether specific uILC subsets are altered in infertility, miscarriage and pregnancy
disorders such as foetal growth restriction and pre-eclampsia. Here, we summarise
recent advances in our understanding of the phenotypic and functional diversity of uILCs
in non-pregnant endometrium and first trimester decidua, and review how these cells may
contribute to successful placental development.
Keywords: uterine natural killer cell, innate lymphoid cell, pregnancy, tissue resident natural killer cell, placenta,
decidua, endometriumINTRODUCTION
The endometrial lining of the uterus is a highly unusual mucosal surface. It is a dynamic tissue that,
in response to steroid hormones from the ovary, undergoes shedding, repair, extensive growth and
remodelling up to 400 times between menarche and menopause (Figure 1A). If pregnancy occurs,
the endometrium transforms into decidua to support implantation of the semi-allogeneic blastocystAbbreviations: Uterine NK (uNK) and uILC collectively refer to either NK or ILC cells respectively in both non-pregnant
(endometrium) or pregnant (decidua) uterine tissue.
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FIGURE 1 | Possible roles of uterine NK cells and ILCs in human endometrium and placental development in humans and mice. (A) Important biological processes in
endometrium during the human menstrual cycle are shown, which may be influenced by local immune cells. Following menstruation, the endometrium undergoes repair
and proliferation under the influence of oestrogen from the ovary and blood supply is re-established involving both spiral arterioles and new capillaries. Following ovulation,
progesterone action results in decidualization of the endometrial stroma and a rapid increase in the number of uNK cells, which comprise up to 70% of the leukocytes
(shown in green) towards the end of the cycle. Dynamics of other ILC populations in human endometrium through the cycle are less well understood. Murine
endometrium cycles by exposure to oestrogen then progesterone but the estrous cycle only lasts ~5 days and there is no menstruation. (B) The human maternal-fetal
interface. Spiral arterioles (SpA) branch from the radial arteries and penetrate the decidua to supply the placenta. Right hand panel shows placental villi bathed in maternal
blood which enters the intervillous space. Placental villi are covered by syncytiotrophoblast, beneath which is the villous cytotrophoblast layer (VT). Anchoring villi attach to
decidua via columns of extravillous trophoblast (EVT) which differentiates from VT. Some EVT migrates down spiral arteries as endovascular trophoblast (ENDT) while
other EVT cells migrate into the decidua as far as the myometrium where they transform into trophoblast giant cells (TGC). Interstitial EVT home to maternal spiral arteries
and participate in their remodelling to provide a low pressure, high capacity blood supply to the placenta. During the first half of pregnancy, when spiral artery remodelling
occurs, trophoblast invasion in humans is much deeper and more extensive than in mice. EVT invading into the decidua encounter maternal leukocytes (shown in green).
In humans in the first trimester, these comprise: ~70% NK and ILCs, 20% macrophages and ~10% T-cells, which include CD4 and CD8 cells. Figure (B) adapted from
Moffett and Colucci (1). (C) Schematic view of pregnant mouse uterus showing multiple implantation sites. Radial arteries branch from the arcuate artery to supply each
developing fetus. The right hand panel shows a uterine cross section cut as indicated by the dotted line, with the arrangement of the placenta and decidua at gestation
day (gd) ~12.5. The radial arteries penetrate through the myometrium, traversing a specialized structure that develops around mid-gestation, known as the mesometrial
lymphoid aggregate of pregnancy (MLAP). The MLAP is not present in humans. Spiral arteries (SpA) branch from the radial artery into the decidua, rich in uterine NK cells
but then merge at the interface between the placenta and the decidua to form a large blood canal that supplies the labyrinthine layer of the placenta where gaseous
exchange takes place between maternal and fetal blood. This blood canal is lined with specialized fetal trophoblast cells (shown coloured purple). The boundary between
the placenta and decidua is delineated by trophoblast giant cells (TGC), which show minimal invasion into the decidua - those few that do invade are largely perivascular.
From gd12.5, glycogen rich trophoblast cells invade more extensively into the decidua (later than timepoint shown here), but spiral artery remodelling is largely complete
by gd12.5. Panel C based on data from Adamson et al. (2).Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 6076692
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trimester of pregnancy, decidual glandular secretions nourish
the developing embryo. Extravillous trophoblast cells (EVT),
derived from the blastocyst, invade into the decidua and
remodel maternal spiral arteries to become high conductance
vessels. These ensure a sufficient blood supply to the developing
foetus from ~10 weeks gestation until term (4). This arterial
transformation by trophoblast must be carefully regulated to
avoid both extremes of insufficient or excessive invasion.
Reduced invasion alters resource allocation between mother and
foetus and is associated with common diseases of pregnancy
including foetal growth restriction (FGR), pre-eclampsia, and
miscarriage (5). Excessive invasion by trophoblast can also lead
to pregnancy complications, for example when the placenta
attaches over caesarean scars or in ectopic pregnancies. Thus,
proper development of the maternal-foetal interface is a tightly
controlled balancing act. The uterine immune system is involved
in regulating this process.
Uterine natural killer cells (uNK) are the most abundant
maternal immune cell in secretory phase endometrium and, if
pregnancy ensues, constitute up to 70% of leukocytes in first
trimester decidua. Numbers then decline substantially towards
term (6). Non-NK ILCs are also present in the uterus, albeit in
lower numbers, throughout the reproductive cycle. These include
ILC1s, ILC3s andLTi-like cells,while the status ofuILC2s isunclear.
A unique feature of uILCs is that during pregnancy they can
encounter trophoblast from a genetically different individual- the
foetus. Therefore, uILC responses are regulated by interactionswith
maternal stromal cells, leukocytes in the decidua and with ligands
expressed on EVT. Growing genetic and functional evidence
suggests that interaction of uNK and other uILC subsets with
EVT regulates the depth of foetal trophoblast invasion (1, 7). In
addition, uILCs likely play important roles in homeostasis and
tissue remodelling as well as in more canonical immune functions
such as controlling pathogens and malignancies. Indeed, uNK can
kill CMV-infected decidual stromal cells and are required for
effective responses to Chlamydia trachomatis (8, 9). Thus, uILCs
likely fulfil multiple functions depending on the context and their
location (10). Moreover, these are likely to differ between species
whichhave developeddifferentmechanisms to sustainpregnancies.
The maternal-foetal interface in human and mouse, and the
potential roles uILCs play are summarised in Figures 1B, C. In
both species, foetally-derived trophoblast cells invade the uterine
mucosa during development of the placenta, although the extent of
invasion is much greater in humans. This brings them into direct
contactwithdecidual leukocytes, leading to the suggestion thatuNK
and uILCs regulate key processes during pregnancy.
The ability to perform a wide range of effector functions may be
facilitated by heterogeneity within the uILC compartment. The
most studied uILC are uNK, originally defined as CD3- CD56+
lymphocytes. There are several recent reviews of uterine ILCs
(11–14). The diversity of uNK was apparent from the first
phenotypic characterisations (15–17) and has become increasingly
evident as high dimensional single cell technologies have been
applied to the endometrium and decidua. Here, we focus on how
these new approaches have expanded our understanding of theFrontiers in Immunology | www.frontiersin.org 3diversity of the uNK niche within ILCs and how these new uNK
subsets may regulate normal placental development. We place
recent findings in the wider context of ILC biology and discuss
several outstanding questions that should guide future studies.NK AND THE ILC FAMILY
OF LYMPHOCYTES
NK cells are members of the ILC family which also contains
ILC1, ILC2, ILC3 and lymphoid tissue inducer cells (LTi) (18).
Lineage studies show that, in both mice and humans, NK cells
and ILCs develop through a common lymphoid progenitor
(CLP) but NK and ILCs then diverge (Figure 2). The latter
proceed through a common helper-like ILC precursor (ChILP)
dependent on the transcription factor PLZF (20). Subsequent
development of the ILC1, ILC2 and ILC3 subtypes depends on
differential expression of transcription factors T-bet, GATA-3
and RORgt respectively (21). In contrast, NK cell development
from CLPs proceeds via an NK precursor and depends upon
Eomes in combination with T-bet (20, 22–25). Several precursors
have been identified that can develop into tissue ILC subsets.
Identification of specific intermediates in human and murine
ILC development is still underway and the mechanisms
controlling ILC development may differ from the proposed
scheme in certain tissues (26). Tissue ILCs also exhibit
considerable plasticity within tissues, so the pathways leading
to NK and other ILCs appear to vary in different organs (19).
Tissue residency is a hallmark of ILCs, which like NK cells, lack
antigen-specific receptors generated by somatic recombination.
Although parabiosis experiments and constitutive cell tagging
approaches in mice show that, under physiological conditions,
ILCs and some NK subsets in non-lymphoid organs are largely
tissue resident and maintained by self-renewal (27, 28), recent
experiments suggest that ILC circulation is more extensive than
previously thought (29). ILC3s can migrate from the intestinal
mucosa to local lymph nodes and low numbers of ILCs circulate
in the blood (30). Thus, the extent to which individual ILC and
NK subsets can exchange with the circulation in different organs
including the uterus is still unclear.
ILCs orchestrate context-specific immune responses and fulfil
non-immunological roles including tissue remodelling and
metabolic homeostasis (21, 31). Whilst the main ILC subtypes
have common features across different organs, they acquire
distinctive characteristics in response to local cytokines and the
tissue microenvironment. Growing evidence for plasticity
between some ILC subsets is also emerging, emphasising the
need for detailed phenotypic and functional characterisation
within each tissue (23, 32, 33). This variation has hampered
efforts to define the identity and function of uterine ILCs.UTERINE ILCs
Although all five main ILC subsets have been identified within
the human uterus, the reports are somewhat conflicting and theirJune 2021 | Volume 12 | Article 607669
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(34–37). This is partly because studies of the functional
properties of uterine ILCs and NK cells were based on
phenotypic markers derived from other tissues. This can be
problematic because of the phenotypic variability in different
locations. Enzymatic disaggregation of tissue can also result inFrontiers in Immunology | www.frontiersin.org 4loss of key markers such as CD56 and NKp44; this is reduced by
use of mechanical dissociation of tissue (35).
Uterine NK Cells
NK cells were identified phenotypically as CD3−CD56+ granulated
lymphocytes in blood (38). Large granular lymphocytes had beenFIGURE 2 | Development and functions of NK cells and ILCs Simplified overview of key stages of ILC development. Scheme shown is largely based on murine data.
Table shows typical cytokines that stimulate the main ILC subsets, together with their principal effector molecules and known immune functions. Phenotypic markers
commonly used to identify human subsets are shown and assumes prior gating on lin-CD45+ cells. CLP common lymphoid progenitor, CILP, common innate
lymphoid progenitor; CHILP, common helper ILP; ILCP, innate lymphoid cell precursor; NKP, NK progenitor; LTiP, lymphoid tissue inducer precursor; LTi, lymphoid
tissue inducer; NFIL3, Nuclear factor, interleukin-3 regulated; ID2, inhibitor of DNA binding 2; GATA3, GATA binding protein 3; PLZF, promyelocytic leukemia zinc
finger; T-bet, T-box transcription factor 21; Eomes, eomesodermin; AhR, aryl hydrocarbon receptor; ROR, Retinoic acid–related orphan receptor; TSLP, thymic
stroma lymphopoietin; Areg, amphiregulin; LT, lymphotoxin; IFNg, interferon-gamma; IL, interleukin; NCR, natural cytotoxicity receptor; NK, natural killer. Figure and
phenotypic markers adapted from Vivier et al. (18) and Guia and Mancinelli (19).June 2021 | Volume 12 | Article 607669
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only with the advent of immunohistochemistry that these were
shown to belong to the NK lineage (15–17). Studies over decades
have relied on gating on CD3−CD56+ to capture NK cells, but this
is now known to capture a mixture of both NK and non-NK ILCs in
various tissues including the uterus (33, 37, 39, 40).
Endometrial NK Cells: NK cells in proliferative phase
endometrium (eNK) comprise ~20% of total leukocytes. After
ovulation, eNK then proliferate vigorously during the secretory
phase which continues through early pregnancy (17, 41). This is
driven by IL-15 secreted by stromal cells in response to
progesterone (42). eNK are CD56bright, express markers of tissue
residency (CD49a, CD69 and CD9), and many canonical NK cell
markers (NKG2A, NKG2D and NKp46) but lack CD16 and
CD57. The family of killer cell immunoglobulin-like receptors
(KIR) are also important in regulating NK activation. KIR
expression on eNK differs compared to matched pbNK as well
as to dNK and is stable over multiple menstrual cycles (43, 44).
Compared with decidual NK cells (dNK), there are very few
functional studies using eNK. They show cytotoxicity against
K562 targets and low levels of spontaneous cytokine secretion,
which is increased upon activation with IL-15 (41, 45, 46). Their
rapid increase after ovulation has led to suggestions that eNK
may be important in implantation. Accurate counting is difficult
because of their uneven distribution and very rapid changes in
number through the cycle, but numerous studies have failed to
establish any consistent alterations in numbers of eNK and
implantation failure or recurrent miscarriage (47). Nor is it
clear that the wide variation in eNK numbers observed
between these patients is functionally significant since it is also
seen in women with normal fertility (48).
First Trimester Decidual NK Cells: In comparison to eNK,
first trimester dNK have been far more extensively studied.
Phenotypically they share many similarities with eNK
including expression of tissue residency markers, lack of CD16
and CD57, and increased proportion of cells that are KIR+ and
NKG2A+ (43, 49–52). Comparison of eNK from the secretory
phase with first trimester dNK, identified over 150 transcripts
that differed >3 fold, highlighting significant changes that arise
after the onset of pregnancy (53). As well as altered transcript
levels, there are changes in RNA splicing, resulting in expression
of inhibitory rather than activating isoforms of individual natural
cytotoxicity receptors (NCR). Ligation of NKp30 or NKp44
therefore induces inhibitory responses in dNK but activation of
pbNK (54). This may contribute to the low cytotoxicity displayed
by dNK towards HLA class I null cell lines and to trophoblast
(55). NK cells can mediate allo-recognition and dNK interact
with EVT as the latter invade into the decidua. Because some of
these receptors differ between mouse and human, the ligand/
receptor interactions between dNK and foetal EVT are distinct in
the two species, requiring caution in extrapolating results
between the two (Figure 3).
Term Decidual NK Cells: As gestation proceeds, the
proportion of dNK decreases and by term lin−CD56+ cells
represent ~20% of CD45+ cells in decidua parietalis (60). They
retain expression of CD9, lack CD16 and CD57, and displayFrontiers in Immunology | www.frontiersin.org 5decreased expression of KIR, LILRB1 and 9kDa granulysin.
There are also functional differences compared with their first
trimester counterparts; term dNK degranulate more readily in
response to PMA/ionomycin stimulation or K562 but show
decreased cytotoxicity to HCMV-infected stromal cells. Thus,
uNK are a dynamic population which vary in both function and
phenotype depending on the stage of the reproductive cycle and
location within the tissue.
ILC1s
ILC1s, originally identified in the tonsils and gut mucosa, are
Tbet+ cells that produce IFN-g in response to IL-12 stimulation
(61). Two human ILC1 subsets have been described: “classical”
ILC1s (CD56−CD94−CD127+CD117−NKp44−) and intra-
epithelial ILC1s (ieILC1s) (CD56+ CD103+) (62). The ILC1
cells identified in the decidua, resemble ieILC1s described in the
gut, which express CD56, perforin and granzymes and are
cytotoxic. ieILC1s express a unique integrin profile including
CD103 and are found enriched in epithelial regions (62). ILC1s
appear phenotypically heterogeneous and even display different
transcription factor requirements for their development in
different tissues so do not readily conform to the scheme
outlined in Figure 2 (63). In secretory phase endometrium no
‘classical CD127+ ILC1’ cells were detected (35) but both ILC1
and ieILC1 subsets are reported in decidua (36, 37). Indeed,
NKp44+CD103+ cells were identified as the major source of
IFN-g within the decidual Lin−CD56+ compartment (64).
Although CD56− ILC1s, ‘classical ILC1s’, are reported in term
decidua, comprising ~3% of the Lin−CD127+ compartment,
their existence is controversial (64). The gating strategy used to
identify ILC1s can capture a mixed population of other
leukocytes and hematopoietic stem cells in some tissues (33).
Current evidence therefore supports the presence of uterine
ieILC1s but the presence of classical ILC1s needs confirming.
ILC2s
Mixed reports also exist for the presence of uterine ILC2s, typically
identified as Lin−CD127+CRTH2+ cells. A preliminary report
showed ILC2s in small numbers in human non-pregnant
endometrium and decidua and suggested they can promote foetal
growth in mice (65). In human term decidua, ILC2s (Lin− CD56−
CD127+ GATA-3+) were the most frequent CD56− CD127+ ILC,
with increased ILC2 in decidua basalis of women with preterm
labour (64). Other studies did not detect CRTH2 expression in
endometrium or decidua (35, 36). These discrepancies may be
explained by the gate used to identify ILCs. As found for ILC1s in
the uterus, when gating on CD127+ cells, no ILC2s are detected in
early decidua but CD127low/neg are fairly abundant (65). Whether
cells corresponding to ILC2s exist in the uterus at all stages of the
reproductive cycle is therefore controversial.
ILC3s
ILC3s and Lymphoid Tissue-inducer-like cells (LTi-like) are
defined by their expression of RORgt (66). LTi-like ILCs are
phenotypically similar to LTi cells, which promote lymph node
formation in the developing foetus. ILC3s can be furtherJune 2021 | Volume 12 | Article 607669
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NCR− ILC3s; the latter are difficult to distinguish from LTi-like
ILCs and have typically been treated as one population. ILC3s are
described in both human and murine uteri (34, 35, 37). In human
endometrium, the majority are RORgt+NKp44+ (~3% of
leukocytes) corresponding to NCR+ILC3s (35, 37). Within the
decidua, NCR+ILC3s produce IL-22 whilst NCR− ILC3s/LTis
produce TNF upon activation (36). Both ILC3 and LTi subsets
also induce the upregulation of adhesion molecules ICAM-1 and
VCAM-1 on decidual stromal cells, suggesting they may be
involved in recruitment of other leukocytes or can perform LTi-
like functions (13, 36). Increased ILC3 proportions have also been
detected in decidua parietalis of women with preterm labour (64).
These studies suggest that ILCs are represented across all
stages of the human reproductive cycle and are dominated by
uNK cells. However, the gating strategies needed to distinguish
these subsets from one another in the uterine mucosa are not
yet clear. For example, new findings that human dNK are
CD56+CD94+ but heterogeneous for CD103 expressionFrontiers in Immunology | www.frontiersin.org 6means it is problematic to identify ieILC1s, which in other
tissues are typically gated as CD56+CD94+/−CD103+ (33, 37,
39, 40). For the same reason the presence of uterine ILC2s and
classical ILC1s is not clearly established.
Origin of Uterine ILCs
The dynamic changes in numbers of uNK and other uILCs in the
endometrium and decidua has led to interest in where they
originate. uNK cells have been the focus of most of these studies.
Since NK cells originate from bone marrow derived precursors,
work has centred on whether uNK cells derive from circulating
CD34+ hematopoietic progenitor cells (HPCs) or NK lineage-
committed precursors that migrate to the uterine mucosa. Others
have examined whether mature blood NK cells can acquire uNK
characteristics in the uterine microenvironment. Following bone
marrow transfer, donor-derived leukocytes, including NK cells,
are detected in endometrium and decidua in both humans and
mice, suggesting that in vivo these can arise from transferred
HPCs (67, 68). Human stage 3 NK-committed precursors can beFIGURE 3 | Major peripheral blood (pbNK) and uterine NK cell (uNK) subsets in human and mouse, with possible trophoblast MHC ligands for selected uNK
receptors. The two main human pbNK subsets are Lin-CD56bright (~10% of total NK) and CD56dim (~90%); in mice the equivalent NK subsets are lin-CD27+
CD11b+ and CD27-CD11b+ (56). In the human uterus, uNK cells are defined as lin-CD56+CD49a+ (or CD56+CD9+, since both CD49a and CD9 are markers of
tissue residency in the uterus). Mouse uterine NK cells are typically gated as lin-NK1.1+NKp46+ and comprise two main subsets, distinguished on the basis of
CD49a and CD49b expression (CD49b is often referred to as DX5). Recent studies have shown that uNK in both species exhibit further heterogeneity (described in
more detail later). The right hand panel shows selected receptors expressed on uNK cells and whether the corresponding MHC ligands are expressed on human or
murine trophoblast cells. Receptors that normally inhibit NK activity are underlined. Note that LILRB1 which is normally considered an inhibitory receptor, has been
reported to function as an activating receptor in uNK cells by some authors (57, 58); conversely NKp44 may function as an inhibitory receptor in uNK (54), so is
shown underlined. C2+HLA-C, indicates an HLA-C allele carrying a C2 epitope. Full details and original references describing expression of each ligand on
trophoblast are available in Gaynor and Colucci (59).June 2021 | Volume 12 | Article 607669
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cells in the presence of IL-15, which is expressed in the
endometrium and decidua (34). However CD34+ progenitors
are also detectable in both human endometrium and decidua and
can rapidly differentiate into NK cells in vitro (69). This suggests
homing of NK precursors derived from bone marrow or
differentiation of stem cells resident in the tissue may both
contribute to uNK populations. The latter is supported by the
finding that CD56+ NK cells develop in human endometrial
tissue xenografted into immunodeficient mice, in response to
steroid hormones (70). Mature human NK cells circulating in
blood also acquire characteristics of uNK cells, after treatment
with cytokines including TGF-b, suggesting that recruitment of
pbNK can contribute to uNK populations (71). The idea that
both in situ differentiation from tissue resident precursors and
recruitment from cells circulating in blood contribute to uNK
populations is supported by elegant parabiosis studies in mice.
These show both mechanisms contribute to increases in uNK at
different times: tissue resident cells proliferate during early
pregnancy in response to decidualization, while a second wave
of recruitment of circulating NK cells augments uNK cell
numbers in the second half of gestation (72, 73). Recent data
from HLA mismatched uterus transplant recipients in humans
suggests that uNK can indeed be replenished from the circulation
(74). This approach could be applied to establish whether other
uILC subsets can also originate from the periphery and whether
peripheral or tissue resident contributions vary during
pregnancy, as seen in the mouse.HIGH RESOLUTION ANALYSIS OF
DECIDUAL NK AND ILC POPULATIONS
It is now apparent that gating strategies used to define specific ILCs
in one tissue may not readily translate to another because key
markers can differ. Recently single cell RNA sequencing
(scRNAseq) and high dimensional mass cytometry (CyTOF) have
allowed ILCs and NK subsets to be reliably identified in different
tissues despite this variation in phenotype and functional responses
(33, 56). These techniques, as well as high parameter flow
cytometry, have recently been applied to first trimester decidua to
provide a more accurate characterization of the phenotype and
functions of ILC subsets in the uterus (39, 40, 75–77).
Analysis by scRNAseq provided the first description of three
distinct decidual NK populations, termed dNK1-3, as well as a
proliferating NK subset (dNKp) and ILC3s (40, 77). dNK1 are
characterised by expression of KIR, LILRB1, CD39 and increased
granzymes. dNK2 express high levels of ITGB2 and anti-
inflammatory ANXA1. Based on their expression signature,
dNK3 resemble intra-epithelial ILC1s. No clusters corresponding
to ILC2s or classical ILC1s were identified. This analysis also
identified significant heterogeneity within other immune, stromal
and epithelial cells and allowed the first systematic analysis of
potential ligand/receptor interactions between uILCs and other
decidual and placental cell types (40, 76, 78). scRNAseq analysis of
luteal phase endometrium also identified several NK subsets
suggesting that heterogeneity in uNK arises before pregnancy (79).Frontiers in Immunology | www.frontiersin.org 7A complementary analysis of lin−CD45+ decidual cells by
CyTOF using a panel of 41 antibodies identified 13 separate
clusters of which 11 can be phenotypically assigned to NK or
ILC subsets (Figures 4A, B). This confirms the presence of
multiple dNK subsets at the protein level (39). Clusters 10-13
(c10-13) correspond to dNK1 in the scRNAseq analysis but are
further separated by differential KIR expression. Based on a similar
receptor staining profile, including high expression of NKG2A and
low expression of KIR and LILRB1, c9 corresponds to dNK2, and
c5 and c8, which differ based on NKG2A and NKp44 expression,
represent dNK3/ieILC1. Two small CD16+ pbNK-like clusters
(c1-2) are probably maternal blood contaminants as
immunohistochemistry has revealed few CD56+CD16+ NK cells
within the decidua itself (17). dNK1 are the most abundant dILC
followed by dNK2 and dNK3/ieILC1, although proportions vary
between donors and can also be affected by cryopreservation
(Figure 4C). These ILC subsets and their phenotypes are
summarised in Figure 4D. Stimulation of ILCs by ‘missing self’
(K562) or PMA/ionomycin revealed that these dNK subsets
significantly differ in their responsiveness, with dNK2 and dNK3/
ieILC1 more responsive than dNK1. These are non-physiological
stimulations and how each subset responds in more relevant assays
such as co-cultures with trophoblast needs exploring.
In the lightof thesenewfindingsa re-evaluationofprevious studies
using pre-determined gating strategies to identify dNK subsets is
possible. Three populations were found using NKp44 and CD103:
NKp44+CD103+, NKp44−CD103+ and NKp44−CD103− (37).
Although NKp44+CD103+ are enriched for dNK3/ieILC1, the
remaining subsets do not directly correlate with those defined by
CyTOF. pbNK cells can display memory-like properties with
expansion of specific NK subsets in CMV infection (80).
Expansions of uNK subsets have been described in both mice (81)
and humans (44, 57, 82). A population of NKG2Chigh LILRB1+,
termed pregnancy-trained decidual NK (PTdNK) is increased in
secondary and subsequent pregnancies. Phenotypically, these most
closely resemble dNK1 and probably represent an expanded dNK1
subpopulation. PTdNK have epigenetic and transcriptomic profiles
that favour IFN-g and VEGF-A production although the functional
studies were performed with dNK activated after IL-15 priming (57).
IFN-g and VEGF-A are not normally produced by freshly isolated
dNK1 unless they are strongly activated after isolation, so their role in
vivo is unclear (83, 84). First pregnancies show a higher risk of low
birth weight and pre-eclampsia, which may be due to better extra-
villous trophoblast invasionandarterial transformation in subsequent
pregnancies (85–87). Further work is required to define the PTdNK
subset more accurately to ascertain if they contribute to this effect.How Do Decidual ILC Populations
Compare With Other Tissues?
ILC subset composition varies between tissues and pathological
states but in first trimester decidua it differs from other normal
mucosal tissues (Figures 4C, 5) (33, 39). Some caution is needed
with this comparison as the gating strategies used in the two
studies are not directly comparable. The lung contains relatively
fewer ieILC1 cells whilst colon, adenoid and tonsil all possess
larger proportions of ILC3s than decidua. Intriguingly, in thisJune 2021 | Volume 12 | Article 607669
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that seen in colorectal tumours with NK and ieILC1-like cells
predominant and few ILC3s (Figure 5). This relative lack of
ILC3s in decidua is consistent with a recent analysis of normal
mucosal tissues, which also demonstrated significant variability
in ILC composition at different sites within the same tissue (63).
dNK1 are unlike tissue resident NK (trNK) present elsewhere;
their expression of high levels of both KIR and NKG2A is unique
(33, 88). For example, liver resident NK (lrNK) subsets are
defined by CD49a and CXCR6. However, CD49a+ lrNK are
KIR+ NKG2A− and CXCR6+ lrNK are KIR− NKG2A+ (89–91).
Similarly, dNK2 may resemble CXCR6+ lrNK with respect to
KIR and NKG2A expression but differ in terms of CD49a
expression. In contrast, dNK3/ieILC1 and dILC3 more closely
resemble their counterparts in other tissues. The presence of
multiple uNK subsets is suggestive of subset-specific functions.Microheterogeneity Within uNK Subsets
Our mass cytometry analysis has revealed further phenotypically
discrete populations within these novel uNK subsets. Many NKFrontiers in Immunology | www.frontiersin.org 8receptors are expressed stochastically, further diversified by
environmental factors including NK cell education, epigenetics
and viral infections as well as genetic differences between
individuals (92, 93). Using Boolean analysis of receptor
combinations, pbNK exhibit a large level of receptor diversity
within the main CD56bright and CD56dim fractions (94). A similar
analysis of CD45+ Lin− CD56+ cells using our CyTOF data
reveals comparable diversity within the decidual NK subsets
(Figure 6). 25 additional markers were included so 225
phenotypic combinations are theoretically possible. For pbNK,
up to 6173 phenotypes were identified for a single donor using 28
markers, with the most frequent phenotype present representing
~0.6-4.6% of total pbNK from six donors. Subsets comprising the
most frequent 20 phenotypes accounted for between 6.1-25.9% in
each donor’s pbNK (Table 1). For dNK, up to 4745 phenotypes
were detected for a single donor. In contrast to pbNK, the top 20
phenotypes represented a larger proportion of the total NK
compartment, ranging from 25.2-44.3% between donors. Cells
expressing KIR (mainly corresponding to dNK1) occur more
frequently in the most common dNK phenotypes in comparison
to pbNK. While overall phenotypic diversity appears similar inA B
DC
FIGURE 4 | ILC subsets identified by mass cytometry of first trimester decidual cells. (A) tSNE landscape of CD45+ CD3- CD19- CD14- HLA-DR- (Lin-)
cryopreserved decidual cells stained by mass cytometry. tSNE is coloured by clusters identified by DensVM clustering. 11 of these clusters can be assigned to NK or
ILC subsets. Cluster 3 is heterogeneous and cluster 4 appears to contain cells damaged by cryopreservation so these were excluded from subsequent analysis.
(B) Phenotypic characterisation of selected clusters. Size of the circle is representative of the proportion of the cluster positive for that marker. Circles are coloured
by intensity of staining for that marker. Intensities have been scaled by marker (ie within each column). Red corresponds to higher expression and grey to lower
expression. Percentage of cells in the cluster staining for each marker is indicated by size of the circles, scaled as shown on the right of the figure. (C) Box plots
show the proportions of designated clusters within the total CD45+ Lin- decidual compartment. Blue dots = cryopreserved samples, Black dots = fresh samples.
[Figure 4A adapted from Huhn et al. (39), where details of the antibody panel are described]. (D) Comparison of decidual NK and ILC clusters identified by single
cell RNA sequencing (scRNAseq) (40) and by mass cytometry (Cytof) (39). Identity of each cluster is based on their profiles of RNA or protein marker expression
respectively. Cytof clusters 10-13, correspond to scRNAseq cluster dNK1 and are distinguished by their KIR expression. Cytof clusters 5,8 are distinguished by NKp44/
NKG2A expression and correspond to scRNAseq cluster dNK3, representing ieILC. Cytof clusters 3 and 4 identified in panel A appear heterogeneous and don’t match
any scRNAseq clusters; identities are not established. ++ is > 75% positive staining of cells with antibody in Cytof; + is 25% to 75%; − is <25%.June 2021 | Volume 12 | Article 607669
Huhn et al. Uterine NK and ILC SubsetsFIGURE 5 | Frequencies of NK and ILC populations in decidua compared with other human tissues. Pie charts showing the frequencies of NK and ILC
subsets in decidua (N = 7) compared with normal and pathological human tissues determined by mass cytometry. All charts, with the exception of first
trimester decidua come from Simoni et al. (n = 4-9 separate donors for each tissue type) (33). For first trimester decidua, Live CD45+CD3-CD19-CD14-
HLA-DR- cells were gated on as the parent population [data from Huhn et al. (39)]. Specified subsets were then identified on a tSNE landscape based on
phenotypic profiles and their proportion within this population calculated. Unassigned cells (grey in decidua) could not be confidently labelled as a particular
subset based on the markers included in the CyTOF panel. For all other tissues, samples were first depleted of T and B cells and then gated on Live
CD45+ FcϵR1a– CD14– CD19– CD123–CD34-CD5- cells. Gating strategies to identify each subset were then as follows: NK cells (purple) = CD94+/-
CD127+/-CD56+CD103-; ieILC1-like (red) = CD94+/-CD127+/-CD56+CD103+; ILC2 (blue) = CD94-CD127+CRTH2+; ILC3 =CD94-CD127+CRTH2-.
[Figure adapted from Simoni et al. and Huhn et al. (33, 39)].FIGURE 6 | dNK receptor repertoire diversity Frequencies of the most common NK cell phenotypes were determined by mass spectrometry in freshly isolated
CD45+Lin−CD56+ decidual NK cells for three selected individuals based on combinations of 26 individual phenotypic markers expressed on each cell. The twenty
most frequent phenotypes detected are shown for each donor Dec1,3,5. Each column represents a phenotype shared by a number of cells; boxes are coloured if
the marker is expressed in that phenotype. Frequencies of each phenotype as a percentage of total CD45+Lin−CD56+ are displayed as a heat map at the bottom of
the figure. Based on analysis of data from Huhn et al. (39).Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 6076699
Huhn et al. Uterine NK and ILC SubsetspbNK and dNK, the decidual NK cell repertoire is dominated by a
more limited number of highly represented phenotypes, possibly
selectively favoured during NK proliferation and maturation.
Some may represent developmental intermediates while others
include effectors that drive important physiological processes
during pregnancy. The immediate challenge is to determine how
the phenotypic diversity of uNK and ILC populations within and
between women influences pregnancy outcomes.WHAT CAN WE LEARN ABOUT THE
FUNCTION OF UTERINE ILCs FROM
MOUSE MODELS?
Establishing the function of human NK cells and ILCs is
challenging because of the rapid changes in cell types andFrontiers in Immunology | www.frontiersin.org 10ongoing uncertainty about which ILCs are present at different
stages of pregnancy. Implantation and early placental
development in the mouse do share some features with humans,
including decidualisation of stromal cells of the uterine mucosa,
and invasion of foetal trophoblast cells into the decidua (Figure 1
and Table 2). Although trophoblast invasion and spiral artery
remodelling is necessary in both species to increase the blood
supply to the developing placenta, this invasion is far more
extensive in humans. Human trophoblast invades both down
the blood vessels (endovascular) and through the decidua
(interstitial) extending as far as the inner myometrium
(Figure 1B). Trophoblast cells mediate the classical fibrinoid
necrosis of the arterial media that transforms these vessels (95,
96). In mice, trophoblast invasion is minimal and limited to the
junctional zone of the placenta during the first 12 days of
gestation. Instead, spiral artery modification is associated with
NK cells which move into the arterial wall (59, 97, 98).TABLE 1 | Phenotypic diversity of CD45+Lin−CD56+ cells in human blood and decidua based on receptor profiles of individual cells analysed by mass cytometry.








captured by 20 most
frequent phenotypes1(%)
Pb1 Blood 25683 6173 1.9 18.6
Pb2 Blood 9736 4509 1.9 13
Pb3 Blood 7892 3563 2.2 14.5
Pb4 Blood 10787 3336 4.6 25.9
Pb5 Blood 4164 2882 0.6 6.1
Pb6 Blood 14483 4673 2.2 19.6
Dec 1 Decidua 24031 3792 2.7 25.2
Dec 2 Decidua 24740 4428 3.8 32.5
Dec 3 Decidua 32197 4745 6.1 36.8
Dec 4 Decidua 24670 3206 5.6 36.2
Dec 5 Decidua 32507 3658 16 44.3
Dec 6 Decidua 32935 3261 4.4 31.4June 2021 |1Frequencies expressed as % of total CD45+Lin−CD56+ cells in blood or decidua. Blood and decidual samples not from matched donors. Data derived from Huhn et al. (39).TABLE 2 | Key Features of human and murine pregnancy models.
Description Human Mouse
Duration 40 weeks ~19 days
Implantation sites Typically one Multiple implantation sites in each uterine horn
Decidualisation of endometrial stromal
cells
Begins in non-pregnant endometrium. Progesterone
dependent
Triggered by embryo at site of attachment. Also progesterone
dependent
Uterine NK cell numbers Proliferate in endometrium before pregnancy Increase
rapidly in first trimester then decline
Few in endometrium
Rapid increase in trNK after implantation starting ~ gestation day
(gd) 4.5
Peak at mid-pregnancy ~gd 10 then decline
Trophoblast invasion Extensive: through decidua and even into myometrium by: Limited: to junctional zone until gd12.
Interstitial trophoblast, Endovascular trophoblast, Placental
bed giant cells
Limited invasion of decidua thereafter by:
Trophoblast giant cells and glycogen cells
Vascular remodelling Associated with endovascular trophoblast in lumen. Associated with NK cell intravasation into smooth muscle of
vessel
Interstitial trophoblast in muscle wall. Mediated in part by IFNg from NK cells
Some evidence for NK involvement before trophoblast
invasion and away from placental bed
Endovascular Trophoblast limited to central canal in placenta
Localisation of NK cells Isolated cells and in aggregates In pregnancy, is limited to
decidua, Not in myometrium
NK cells in decidua and in the MLAp, embedded in the
myometrium(MLAp is the mesometrial lymphoid aggregate of pregnancy, not seen in humans).Volume 12 | Article 607669
Huhn et al. Uterine NK and ILC SubsetsNonetheless, invading trophoblast cells do encounter maternal NK
and ILCs in the murine decidua later in pregnancy after spiral
artery remodelling is completed.
There are also important differences in timing as well as
localisation of ILC populations. Decidualization is always
characterized by extensive accumulation of NK cells in both
species, but in humans this process begins in the endometrium,
so large numbers of proliferating NK cells are present even before
pregnancy begins. In the mouse, NK numbers do not increase
until decidualization is triggered by implantation of the embryo.
In both species NK cells increase rapidly during the first
trimester but decline by term (6, 11). In mice, at mid-gestation,
ILCs are located in the mesometrial lymphoid aggregate of
pregnancy (MLAp) which develops in the myometrium (11).
No such structure exists in humans and the function of the
MLAp is unknown. It may participate in the regulation of blood
flow since the uterine artery that supplies each implantation site
coils through it (99). In addition, NK-derived IFNg is a key
cytokine in murine pregnancies but it is not a major cytokine
produced by the main dNK1 subset in humans. Despite these
apparent differences in anatomy and cellular dynamics, human
and murine pregnancy share key features. These include
trophoblast invasion into the decidua and the involvement of
both foetal trophoblast and maternal uNK cells in spiral artery
remodelling to ensure sufficient blood reaches the haemochorial
placenta. This suggests mice can provide a useful model to study
the role of NK cells and ILCs in placental development.
NK cells and ILC1s are the most abundant leukocytes in the
pregnant mouse uterus (~30% of total leukocytes at mid-
gestation), significantly lower than in human first trimester
decidua (35). There are three subsets: tissue resident NK (trNK),
CD49a+Eomes+, conventional NK (cNK), CD49a−Eomes+, and
ILC1s, CD49a+ Eomes− (Figure 7A). These all change rapidly in
number and location throughout the reproductive cycleFrontiers in Immunology | www.frontiersin.org 11(Figure 7B). Prior to puberty, mouse endometrium contains
predominantly ILC1s. These decline after puberty while cNK
and trNK increase (81). ILC2s and ILC3s are also present in low
numbers prior to pregnancy, the latter comprising both LTi-like
and NCR+ ILC3s (35, 100). ILCs are distributed throughout the
tissue in a subset-specific manner. At gestational day 11.5 of
pregnancy (gd 11.5), the decidua basalis and MLAp are
composed of mainly cNK or trNK respectively. ILC2 and ILC3s
are absent from the decidua (35, 36). As outlined when discussing
the origins of uNK and ILCs, different rates of subset proliferation,
influx from blood or conversion between ILC subsets within
the uterus may all contribute to these rapid changes in
cellular composition.
Relating human decidual ILC subsets to their murine
counterparts is difficult. dNK1 may be analogous to trNK that
express high levels of Ly49, Eomes and Ki-67 (28, 81).
Murine cNK resemble circulating NK in humans but cNK are
present in large numbers in murine decidua whilst CD16+ pbNK
are rarely seen in human decidual tissue (17, 35, 73). Murine
uILC1 expand in secondary pregnancies and express CXCR6, a
hallmark of antigen-specific NK memory cells (101). Thus, they
may be the functional counterparts to human PTdNK ‘memory’
cells but differ in their low Ly49 expression (57, 81). How human
dNK2 and dNK3/ieILC1 relate to murine decidual ILCs is also
unclear. Murine ieILC1 in the gut are Nfil3-dependent NKp46+
NK1.1+ CD160+ (62). However, Nfil3-/- mice contain both
uterine trNK and ILC1 but lack cNK cells (100). The
difficulties in directly correlating murine and human dILC
subsets may reflect the anatomical differences between human
and mouse placentation as well as the menstrual versus oestrus
cycles in which ILCs and uNK develop preceding pregnancy.
Nevertheless, further characterisation may reveal functional
homologies between phenotypically distinct uterine ILC
subsets between the species.A B
FIGURE 7 | Dynamic changes of NK and ILC1s in the mouse uterus before and after pregnancy (A) Gating strategy to identify uterine NK and ILC1 subsets. Cells
isolated from whole uterus were analysed together. Representative 2D FACS plot is from gestational day 9.5 (gd 9.5) and gated on Live CD45+CD3−CD19−
CD11blow/- NK1.1+NKp46+ cells. ILC1s (red line) are CD49a+ Eomes−, tissue resident NK (trNK, blue) are CD49a+Eomes+, conventional NK (cNK, gold) are
CD49a− Eomes+. (B) Proportions of indicated uterine subsets at different stages of the reproductive cycle as a percentage of the total Live CD45+CD3−CD19−
CD11blow/- NK1.1+NKp46+ cells. w = weeks of age, gd = gestational day [Figure adapted from Filipovic et al. (81)].June 2021 | Volume 12 | Article 607669
Huhn et al. Uterine NK and ILC SubsetsFUNCTIONS OF UTERINE ILC
POPULATIONS DURING PREGNANCY
Evidence highlighting the importance of uNK cells in supporting
successful pregnancies has come from both humans and mice.
Loss of functional NK cells and/or ILCs in a variety of mouse
models is associated with decidual abnormalities and reduced
vascular remodelling (102) and foetal growth restriction (98, 100,
103, 104). For example, pregnancies from an NK- and T cell
deficient mouse model, tgϵ26, exhibit smaller litters and lower
birth weights. Normal birth phenotypes could be restored by
bone marrow grafts from SCID mice that lack B and T cells
but possess NK cells (105). These changes are in part due to
loss of IFNg secretion by NK cells, since they are rescued by
systemic IFNg administration and similar effects are seen in mice
lacking IFNg or its receptor (102, 103). Even deletion of single
receptors on maternal NK cells can result in abnormal foetal
development. Mice lacking Nkg2a, Ncr1 or AhR show defective
NK cell maturation, abnormal spiral artery remodelling and
lower foetal weights (106, 107). Depletion of NK cells in
pregnant rats also causes abnormal arterial remodelling and
hypoxia, accompanied by differentiation of more invasive
trophoblast resulting in abnormal placental development (108).
The roles of other ILCs in pregnancy are much less well
understood. Mice lacking the transcription factor Nfil3/E4bp4
show greatly reduced numbers of cNK and ILC2s in the uterus
but retain trNK, ILC1 and ILC3s. This is associated with
placental abnormalities and reduced foetal growth indicating
that the altered ILC repertoire affects the outcome of pregnancy
(100). The foetal growth restriction inNfil3-/- mice is reversed by
infusion of pleiotrophin, supporting the idea that NK or ILC
subsets produce factors in addition to IFNg that promote
placental development, but the detailed mechanisms
responsible are unclear (104).
Regulation of Trophoblast Migration
A unique feature of pregnancy is that dILCs interact with EVT
from the foetus as well as with maternal cells in the decidua.
Following implantation, in both humans and mice, foetally-
derived trophoblast migrate into the decidua where they
encounter maternal immune cells. These foetal cells express an
unusual repertoire of MHC class I antigens: human EVT is
negative for HLA-A and -B but expresses polymorphic HLA-C
and oligomorphic HLA-E and HLA-G molecules (109).
Trophoblast are always MHC class II negative. Murine
trophoblast from C57BL/6 mice express the MHC class I
antigen H-2Kb but very low levels of H-2Db and Qa-1b. Many
of the receptors on uNK that recognise these polymorphic MHC
molecules are also highly variable and include members of the
killer cell immunoglobulin-like receptors (KIRs) in humans or the
Ly49 family in mice (Figure 3). The dNK1 subset in particular
expresses relevant receptors for trophoblast HLA molecules,
including NKG2A, LILRB1 and members of the KIR family
(Figures 3, 4B). Their activation status can therefore be
influenced by both foetal and maternal ligands. Maternal KIR
recognition of HLA-C molecules on EVT is of particular interestFrontiers in Immunology | www.frontiersin.org 12because both KIR and HLA-C genes are highly polymorphic so
each pregnancy is characterized by different combinations of these
genes, resulting in variable activation or inhibition of dNK.
Genetic studies of large pregnancy cohorts suggest that women
with a KIR AA genotype are at increased risk of pregnancy
disorders when the foetus has an HLA-C allele carrying a C2
epitope (C2+HLA-C). This combination results in strong
inhibitory signals to uNK via maternal inhibitory KIR2DL1
binding to foetal C2+HLA-C on EVT and is associated with
increased risk of pre-eclampsia, foetal growth restriction and
miscarriage, although not all studies concur (110–113). In
contrast, combinations of maternal KIR and foetal HLA-C
which favour activation through KIR2DS1 or KIR2DS5 are
associated with protection from pre-eclampsia and increased
birth weight (110, 112, 114–116).
These are all disorders of pregnancy in which EVT migration
and vascular remodelling is reduced (5). More recently the
presence of the strongly inhibitory allele KIR2DL1*003 in
mothers, combined with foetal C2+HLA-C ligand has been
shown to further increase risk in a dose dependent manner
(117). Thus, binding of a specific inhibitory receptor expressed
on uNK with the corresponding ligand on EVT can affect
pregnancy. These effects are likely to be mediated by dNK1
since they are the main KIR-expressing cells (Figure 4B). This
idea is supported in a mouse model in which the addition of a
single additional MHC molecule (H-2Dd) to the foetal genome
results in abnormal uterine artery remodelling and reduced foetal
growth. This suggests that maternal recognition of a single
paternally-derived H-2Dd molecule influences pregnancy
outcome (98). Whether the mechanism involves direct
recognition of paternal H2-Dd expressed on trophoblast by
inhibitory Ly49 receptors on maternal dNK cells, as seems to
occur for human dNK1 and C2+HLA-C on EVT, is not yet
certain. In humans, the role of other dILC subsets is less clear.
dNK2 and dNK3/ieILC1 express receptors for HLA-E and HLA-G
and other ligands on trophoblast, but these are not significantly
polymorphic, so will not vary between pregnancies (39, 40). dNK2
and dNK3 respond vigorously to activation, but how they respond
to EVT in vivo and how the resulting cytokine responses
contribute to pregnancy success, is not known. Patients with
SCID due to mutations in IL2RG or JAK3, have very low levels
of ILC and NK cells in blood, gut and skin after hematopoietic
stem cell transplantation (HSCT). Despite this, two women had
clinically normal pregnancies after HSCT and healthy babies of
average weight (30). While this study did not investigate uterine
ILCs in these women, the results suggest NK cells and other ILCs
are not essential for reproduction under normal conditions, but
can influence pregnancy outcome by fine-tuning placental
development and hence foetal growth. This is likely achieved by
fulfilling multiple functions including regulating trophoblast
invasion, and remodelling of the vasculature and decidual tissue.
What are the critical responses triggered by KIR in dNK that
might affect placental development and pregnancy outcome?
dNK produce a wide array of chemokines and cytokines upon
stimulation with PMA plus ionomycin, or by ligation of
activating receptors (37, 52, 118, 119). Ligation of activatingJune 2021 | Volume 12 | Article 607669
Huhn et al. Uterine NK and ILC SubsetsKIR to simulate dNK/EVT interactions in the decidua stimulates
secretion of GM-CSF and CXCL10, which have been shown to
increase EVT migration (52, 115, 119). In a 3D microfluidics
model, primary trophoblast migrate towards a microchannel
containing uNK-conditioned medium following activation of
KIR2DS1 (Figure 8) (120). uNK have also been shown to
secrete TGF-b which reduces EVT migration and this effect
changes with gestational age, so uNK responses can potentially
enhance or decrease EVT migration (121). Whilst no migration
model can replicate the complex tissue environment of the
decidua, these genetic and functional studies suggest ligation of
activating KIR on dNK can modulate EVT behaviour and thus
affect blood flow to the placenta.
Vascular Remodelling in Decidua
and Non-Pregnant Endometrium
The role of uNK-derived IFNg in vascular remodelling in murine
decidua is well established (102). Impaired vascular remodelling
in the decidua of mice lacking NK cells or specific NK receptors,
early in gestation shows that uNK cells may directly participate
in this process prior to the arrival of trophoblast (122). This may
be a direct effect on the arteries as they infiltrate the media, unlike
in humans where uNK are seen around the arteries but not in
their wall. Murine uNK also secrete VEGF-C and mice lacking
the corresponding receptor VEGFR3 on endothelial cells show
reduced vessel remodelling and foetal growth restriction. This
shows soluble factors secreted by uNK in mice can target
endothelium lining the arteries, as well as the surrounding
smooth muscle (123). There is indirect evidence that uNK may
also influence spiral arteries around which they are seen to
cluster in human endometrium and decidua (95, 124). dNK
produce MMP-9 which breaks down extracellular matrix (ECM)
of the vascular smooth muscle wall and angiogenic factors such
as VEGF-C and angiopoietins-1 and -2 (119, 125–127).
Although these could disrupt the vascular smooth muscle wall,Frontiers in Immunology | www.frontiersin.org 13as their effect is partially abrogated by Ang-2 inhibition using in
vitro models, little is known about the mechanisms by which
human uNK or EVT actually influence vascular remodelling in
vivo (121, 128, 129). Evidence that NK cells can play a role in
regulating the vascular remodelling of the human endometrium
prior to pregnancy is more compelling. Clusters of eNK around
spiral arteries express angiogenic factors including VEGF-C and
PLGF which can regulate endothelial cell function (125).
Administration of a progesterone modulator (Asoprisnil) to
women results in absence of eNK, altered arterial morphology
and no menstrual bleeding (42). Asoprisnil blocks IL-15 secretion
by stromal cells in response to progesterone. Whether the
outcomes are due to the reduced uNK or other uILCs or a
consequence of blocking other actions of progesterone is
unclear. The role of uNK in modifying the arterial media needs
exploring further as the signals triggering menstruation and
decidual breakdown in miscarriage are still essentially unknown
(129). One suggestion is that eNK use the activating receptor
NKG2D to kill senescent stromal cells emerging during the
secretory phase (130). NK cells kill senescent cells in tumours
and in mouse models of liver fibrosis, but whether this is
important for homeostasis in cycling human endometrium in
vivo needs verification (131, 132).
Regulation of Local Immune Responses
in the Decidua
It is clear that dNK can recognise both maternal and paternal
HLA-C expressed by invading EVT, but allogeneic trophoblast
are also potential targets for maternal T cells. dNKs have been
shown to secrete cytokines and chemokines which have
immunoregulatory functions, leading to suggestions they
contribute to foetal-specific T cell tolerance in the decidua via
a plethora of mechanisms (133, 134). For example, dNK
activated in vitro to secrete IFNg, drives IDO production by
decidual CD14+ cells and induces expansion of regulatory T cellsA B
FIGURE 8 | Ligation of activating KIR on uNK affects human trophoblast migration in vitro. (A) Cartoon showing a cross section of a microfluidics device to study
effects of uNK supernatants on migration of extravillous trophoblast (EVT) . Primary human EVT isolated from first trimester placentas are stained with tracker dye
(blue) and embedded in Matrigel in the central channel. Cells are tracked in real time as they move between two side channels. These side channels have medium
constantly flowing through them and can be supplemented with other factors or supernatants conditioned by uNK cells to create a gradient. (B) Plot showing motility
of EVT towards or away from a microchannel containing uNK-conditioned medium. Freshly isolated uNK were purified from decidua using microbeads and KIR2DS1
was activated by EB6 antibody cross-linking for 12 hours. Stimulation conditions are shown on x-axis. On average, EVT display increased motility towards a channel
containing supernatant from uNK stimulated by KIR2DS1 cross-linking. This is reduced by the addition of neutralising anti-GM-CSF in the supernatant. Control is
ligation with isotype matched irrelevant IgG. Motility is calculated by subtracting the number of cells migrating upstream towards the uNK supernatant channel by the
number of cells migrating away and dividing this by the total number of cells, [Figure adapted from Abbas et al. (120)].June 2021 | Volume 12 | Article 607669
Huhn et al. Uterine NK and ILC Subsets(Treg) (135). A caveat is that many functional in vitro studies use
dNK stimulated by unphysiological levels of IL-15 or other
factors and their relevance is questionable. Freshly isolated
dNK typically produce low levels of IFNg and other cytokines,
unless strongly activated after isolation (83, 126, 136), and
decidual stromal cells have also been reported to secrete IFNg
(137). New approaches such as scRNAseq and spatial
transcriptomics are required to investigate how uNK influence
responses of other immune cells within the decidua in vivo.
Recently, the ectonucleotidase, CD39, was found to be expressed
by dNK1; this could combine with CD73 on EVT to convert ATP to
adenosine, which is associated with local immune suppression (40,
74). Trophoblast-specific T cells are likely to be HLA-C restricted,
since this is the only polymorphic HLA-molecule on trophoblast. In
term decidua, Tregs are induced following expansion of T cells in
the decidua of HLA-C mismatched pregnancies (138). Many
potential mechanisms favouring T cell tolerance in the decidua
have been demonstrated in vitro, but whether effector T cells ever
cause foetal loss in humans, and if dysfunction of dNK or other
dILCs contribute to this, is not yet established (1, 133, 139).
Despite the immunomodulatory environment in the decidua,
maternal immune cells including ILCs must be able to respond to
pathogens. For example, uILC3s produce IL-22 which maintains
mucosal integrity, and has been shown tomaintain pregnancies in a
mouse model of infection-induced pregnancy loss (140). dNK can
also counteract infections directly; they inhibit infection of human
decidualmacrophagesbyHIV in vitro andkill decidual stromal cells
infectedwithHCMV(141). dNKexpressing an activatingKIRwere
more cytotoxic against infected decidual stromal cells than dNK
lacking that activating receptor. This effect was enhanced when the
stromal cells also expressed the cognate ligand for the activatingKIR
(8, 83). dNK have also been shown to suppress infection by Listeria
monocytogenes of primary trophoblast cells and decidual
macrophages without killing the infected cells (142). Exactly
which dNK or dILC subsets are responsible for these
antipathogen effects is not established. Thus, uILCs contribute
through multiple redundant mechanisms to enhance the
resilience of pregnancy to various challenges including infection
of the uterine mucosa, while accommodating the invasion of
semiallogenic trophoblast.SUMMARY AND FUTURE QUESTIONS
Uterine ILCs have proved challenging to study because, although
they share characteristics with ILCs in other tissues, they have
distinctive phenotypes and functions. The factors responsible for
this in the non-pregnant endometrium and the decidual
microenvironment remain poorly understood. Through the
application of scRNAseq combined with mass and flow
cytometry we now have a better understanding of which ILCs
are present before and during pregnancy (Figures 4C, 5 and
Table 3). In first trimester decidua the predominant ILCs are
dNK1, approximately two fold higher than either dNK2 or dNK3/
ieILC1s, and the overall composition most resembles mucosal
tumours. Our current understanding of uterine ILCs and their
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Huhn et al. Uterine NK and ILC Subsetsinvestigating uNK functions were carried out prior to the
discovery of other uILCs, which would have contaminated these
preparations. Some of these questions will need to be revisited to
establish the functions of different uILC subsets at each stage of the
reproductive cycle. A key new finding has been the identification
of three distinct decidual NK subsets, dNK1-3. Much of the
existing dNK literature focuses on KIR-expressing dNK which
are largely dNK1; the properties and functions of the dNK2 and
dNK3 subsets remain to be determined, with dNK3 resembling
ieILCs in other tissues. These findings raise a number of questions
for future basic and clinically applied research regarding uILCs
and uNK cells in particular:
1. What NK and ILC subsets are present and how can they be
identified?
Identification of clusters in high dimensional datasets
often relies on ‘emergent’ properties where subtle
differences across many markers in combination distinguish
a subset (143). For human uILCs there is no consensus on
simple 2D gating strategies to identify subsets across all the
stages of the reproductive cycle. Further work is required to
reliably identify and analyse the phenotype and functions of
uILC subsets in endometrium and throughout pregnancy.
2. Where are the NK and ILC subsets located and how does
this change?
Recent mouse data suggests that the composition of
mouse uILCs changes throughout reproductive life and that
some uILCs are concentrated at discrete locations.
Understanding where human and mouse uILC and uNKFrontiers in Immunology | www.frontiersin.org 15subsets localise in the endometrium and during pregnancy
will be essential to understanding their functions.
3. What are the origins of NK and ILCs in the uterus?
ILC development in different tissues appears to have
divergent pathways as demonstrated by the effects of Nfil3
deficiency on trNK and cNK subsets in the mouse uterus.
Which subsets develop in situ and which arise from
circulating precursors in the human uterus can be
addressed by analysing uILCs from patients with bone
marrow or uterine transplants with HLA-mismatched
donors (74, 144). ILCs also demonstrate considerable
plasticity and the relationships between uNK subsets and
other uILCs is unclear, although recent evidence suggests that
dNK2 can convert to cells resembling dNK1 in vitro (76).
4. What roles do NK and ILC play in repair and homeostasis
of the uterine mucosa?
While dNK1 appear to be specialised for interactions with
EVT through KIR, the roles played by other uNK and uILC
subsets is poorly understood in physiological or pathological
situations. Itwill be important tounderstandhow they contribute
to mucosal integrity, metabolism, tissue remodelling and
antipathogen responses in endometrium and decidua.
5. Is the huge diversity of phenotypes within known subsets
biologically meaningful?
In addition to subset discovery, mass cytometry has
revealed a previously unappreciated diversity even within
well characterised subsets. Lin−CD56+ uNKs exhibit
comparable diversity to that reported in pbNK with
thousands of related phenotypes defined by stochastic NKFIGURE 9 | Characteristics of innate lymphoid cells identified in the human uterus by scRNAseq and mass cytometry. Typical frequencies of each ILC type are given
as a percentage of total decidual CD45+HLADR −CD14−CD19−CD3− (Lin−) gate in freshly isolated cells (not cryopreserved). Frequencies in endometrium will be
different. Transcription factor (TF) expression and cytokine responses following PMA/ionomycin stimulation are based on mass cytometry data of Huhn et al. (39). TFs
and cytokines listed in bold, indicate stronger staining. For functional responses, blank = 0-10%, + = 10-25%, ++ = 25-50%, +++ = 50+% staining by mass cytometry.June 2021 | Volume 12 | Article 607669
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level variation is biologically meaningful and whether it affects
functions such as embryonic implantation and pregnancy
outcome is a future challenge.
6. Do uNK have memory?
uILC subsets with a specific phenotype may expand in
response to pregnancy or pathogens as previously observed
in pbNK (44, 57, 81), where some NKG2C+ pbNK expand in
response to CMV infection. How these adaptive NK
responses influence pregnancy outcome or pathology will
be an important future research question.
In summary, current evidence suggests that uNK and
uILCs are important in supporting aspects of normal
placental development in both humans and mice, but the
effects of NK or ILC deficiency are nuanced. Loss of functional
uNK or uILCs is associated with increased incidence of foetal
growth restriction, pre-eclampsia or premature labour in
murine models. In humans, these can have life-long
consequences including increased cardiovascular and
neurological disease (145). Genetic studies of large human
cohorts support the idea that variants known to alter NK
responsiveness are associated with increased risks of pregnancy
disorders (110–112, 116). Understanding how uNK and other
uILCs contribute to disorders of implantation and pregnancy
will be a major challenge for future studies. Knowledge of
subset functions will allow accurate assessment of changes in
clinical pathology and infertility and may pave the way for
targeted immunotherapies.AUTHOR CONTRIBUTIONS
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